CAMAISA ALLAN (CEO, President and Chairman) sold 1.1% of their position (850.00 shares) of CALIDI BIOTHERAPEUTICS, INC. on the open market
Open‑market sale worth $1.2K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/16/2025ACC: 0001493152-25-028030
DirectorOfficer10% Owner· CEO, President and Chairman
Since Sep 2023
-850.00
Net shares
Net seller
$1.2K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
850.00 disposed
Non-Derivative Transactions1
Common Stock
Indirect
Shares
−850.00
Price / share
$1.46
Trade value
$1.24K
% of position
1.1%
12/12/2025
77.80K→76.95K
Total
Net shares
−850.00
Net value
-$1.24K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 12/12/2025 | S · Sale | −850.00 | $1.46 | $1.24K | 1.1% | 77.80K | 76.95K |
| Total | −850.00 | -$1.24K | ||||||
Derivative Transactions0
No derivative transactions reported